A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Cancer Cell

Volumn 10, Issue 6, 2006, Pages 515-527

  Neve, Richard M ^a,b   Chin, Koei ^b   Fridlyand, Jane ^b,f   Yeh, Jennifer ^b   Baehner, Frederick L ^b   Fevr, Tea ^b   Clark, Laura ^a   Bayani, Nora ^a   Coppe, Jean Philippe ^a   Tong, Frances ^c   Speed, Terry ^c   Spellman, Paul T ^a   DeVries, Sandy ^b   Lapuk, Anna ^a   Wang, Nick J ^a   Kuo, Wen Lin ^a   Stilwell, Jackie L ^a   Pinkel, Daniel ^b   Albertson, Donna G ^b   Waldman, Frederic M ^b   McCormick, Frank ^b   Dickson, Robert B ^g   Johnson, Michael D ^g   Lippman, Marc ^h   Ethier, Stephen ^d   Gazdar, Adi ^e   Gray, Joe W ^a,b   more..

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g GEORGETOWN UNIVERSITY   (United States)

^h UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRASTUZUMAB;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL LINE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 33845209913     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2006.10.008     Document Type: Article

References (57)

1. Abd El-Rehim D.M., Pinder S.E., Paish C.E., Bell J., Blamey R.W., Robertson J.F., Nicholson R.I., and Ellis I.O. Expression of luminal and basal cytokeratins in human breast carcinoma. J. Pathol. 203 (2004) 661-671
2. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100 (2003) 3983-3988
3. Albertson D.G., Collins C., McCormick F., and Gray J.W. Chromosome aberrations in solid tumors. Nat. Genet. 34 (2003) 369-376
4. Alimandi M., Romano A., Curia M.C., Muraro R., Fedi P., Aaronson S.A., Di Fiore P.P., and Kraus M.H. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene 10 (1995) 1813-1821
5. Beck Jr. G.R., Zerler B., and Moran E. Gene array analysis of osteoblast differentiation. Cell Growth Differ. 12 (2001) 61-83
6. Carter T.A., Wodicka L.M., Shah N.P., Velasco A.M., Fabian M.A., Treiber D.K., Milanov Z.V., Atteridge C.E., Biggs III W.H., Edeen P.T., et al. Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases. Proc. Natl. Acad. Sci. USA 102 (2005) 11011-11016
7. Cattoretti G., Andreola S., Clemente C., D'Amato L., and Rilke F. Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas. Br. J. Cancer 57 (1988) 353-357
8. Charafe-Jauffret E., Ginestier C., Monville F., Finetti P., Adelaide J., Cervera N., Fekairi S., Xerri L., Jacquemier J., Birnbaum D., and Bertucci F. Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 25 (2006) 2273-2284
9. Cheng K.W., Lahad J.P., Kuo W.L., Lapuk A., Yamada K., Auersperg N., Liu J., Smith-McCune K., Lu K.H., Fishman D., et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat. Med. 10 (2004) 1251-1256
10. Chin K., DeVries S., Fridlyand J., Spellman P., Roydasgupta R., Kuo W.-L., Lapuk A., Neve R., Qian Z., Ryder T., et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10 (2006) 529-541 this issue
11. Chung C.H., Bernard P.S., and Perou C.M. Molecular portraits and the family tree of cancer. Nat. Genet. 32 Suppl (2002) 533-540
12. Dontu G., Abdallah W.M., Foley J.M., Jackson K.W., Clarke M.F., Kawamura M.J., and Wicha M.S. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17 (2003) 1253-1270
13. Dontu G., Al-Hajj M., Abdallah W.M., Clarke M.F., and Wicha M.S. Stem cells in normal breast development and breast cancer. Cell Prolif. 36 Suppl 1 (2003) 59-72
14. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95 (1998) 14863-14868
15. Ethier S.P., Mahacek M.L., Gullick W.J., Frank T.S., and Weber B.L. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res. 53 (1993) 627-635
16. Feldman R.J., Sementchenko V.I., Gayed M., Fraig M.M., and Watson D.K. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. Cancer Res. 63 (2003) 4626-4631
17. Fridlyand J., Snijders A.M., Ylstra B., Li H., Olshen A., Segraves R., Dairkee S., Tokuyasu T., Ljung B.M., Jain A.N., et al. Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer 6 (2006) 96
18. Gazdar A.F., Kurvari V., Virmani A., Gollahon L., Sakaguchi M., Westerfield M., Kodagoda D., Stasny V., Cunningham H.T., Wistuba I.I., et al. Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int. J. Cancer 78 (1998) 766-774
19. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
20. Hodgson G., Hager J.H., Volik S., Hariono S., Wernick M., Moore D., Nowak N., Albertson D.G., Pinkel D., Collins C., et al. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat. Genet. 29 (2001) 459-464
21. Hyman E., Kauraniemi P., Hautaniemi S., Wolf M., Mousses S., Rozenblum E., Ringner M., Sauter G., Monni O., Elkahloun A., et al. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res. 62 (2002) 6240-6245
22. Hynes N.E., and Lane H.A. ERBB receptors and cancer: The complexity of targeted inhibitors. Nat. Rev. Cancer 5 (2005) 341-354
23. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., and Speed T.P. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 (2003) 249-264
24. Jain A.N., Tokuyasu T.A., Snijders A.M., Segraves R., Albertson D.G., and Pinkel D. Fully automatic quantification of microarray image data. Genome Res. 12 (2002) 325-332
25. Jeffrey S.S., Lonning P.E., and Hillner B.E. Genomics-based prognosis and therapeutic prediction in breast cancer. J. Natl. Compr. Canc. Netw. 3 (2005) 291-300
26. Jones C., Mackay A., Grigoriadis A., Cossu A., Reis-Filho J.S., Fulford L., Dexter T., Davies S., Bulmer K., Ford E., et al. Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. Cancer Res. 64 (2004) 3037-3045
27. Kallioniemi O.P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., and Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10 (1994) 231-243
28. Korsching E., Packeisen J., Agelopoulos K., Eisenacher M., Voss R., Isola J., van Diest P.J., Brandt B., Boecker W., and Buerger H. Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis. Lab. Invest. 82 (2002) 1525-1533
29. Kuperwasser C., Chavarria T., Wu M., Magrane G., Gray J.W., Carey L., Richardson A., and Weinberg R.A. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl. Acad. Sci. USA 101 (2004) 4966-4971
30. Lane H.A., Beuvink I., Motoyama A.B., Daly J.M., Neve R.M., and Hynes N.E. ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency. Mol. Cell. Biol. 20 (2000) 3210-3223
31. Larramendy M.L., Lushnikova T., Bjorkqvist A.M., Wistuba I.I., Virmani A.K., Shivapurkar N., Gazdar A.F., and Knuutila S. Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines. Cancer Genet. Cytogenet. 119 (2000) 132-138
32. Lim K.C., Lakshmanan G., Crawford S.E., Gu Y., Grosveld F., and Engel J.D. Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system. Nat. Genet. 25 (2000) 209-212
33. Loo L.W., Grove D.I., Williams E.M., Neal C.L., Cousens L.A., Schubert E.L., Holcomb I.N., Massa H.F., Glogovac J., Li C.I., et al. Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes. Cancer Res. 64 (2004) 8541-8549
34. Mahon F.X., Deininger M.W., Schultheis B., Chabrol J., Reiffers J., Goldman J.M., and Melo J.V. Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: Diverse mechanisms of resistance. Blood 96 (2000) 1070-1079
35. Nahta R., Takahashi T., Ueno N.T., Hung M.C., and Esteva F.J. P27(kip1) down-regulation is associated with trastuzumab resistance in breast cancer cells. Cancer Res. 64 (2004) 3981-3986
36. Neve R.M., Sutterluty H., Pullen N., Lane H.A., Daly J.M., Krek W., and Hynes N.E. Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells. Oncogene 19 (2000) 1647-1656
37. Neve R.M., Schaefer C., Buetow K., and Gray J.W. Genomic events in breast cancer progression. In: Harris J.R., Lippman M.E., Morrow M., and Osborne C.K. (Eds). Diseases of the Breast. Third Edition (2004), Lippincott Williams & Wilkins, Philadelphia 383-395
38. Nielsen T.O., Hsu F.D., Jensen K., Cheang M., Karaca G., Hu Z., Hernandez-Boussard T., Livasy C., Cowan D., Dressler L., et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin. Cancer Res. 10 (2004) 5367-5374
39. Perou C.M., Jeffrey S.S., van de Rijn M., Rees C.A., Eisen M.B., Ross D.T., Pergamenschikov A., Williams C.F., Zhu S.X., Lee J.C., et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl. Acad. Sci. USA 96 (1999) 9212-9217
40. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Akslen L.A., et al. Molecular portraits of human breast tumours. Nature 406 (2000) 747-752
41. Pollack J.R., Sorlie T., Perou C.M., Rees C.A., Jeffrey S.S., Lonning P.E., Tibshirani R., Botstein D., Borresen-Dale A.L., and Brown P.O. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl. Acad. Sci. USA 99 (2002) 12963-12968
42. Radisky D.C., and Bissell M.J. Cancer. Respect thy neighbor!. Science 303 (2004) 775-777
43. Roylance R., Gorman P., Harris W., Liebmann R., Barnes D., Hanby A., and Sheer D. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res. 59 (1999) 1433-1436
44. Saldanha A.J. Java treeview-Extensible visualization of microarray data. Bioinformatics 20 (2004) 3246-3248
45. Shadeo A., and Lam W.L. Comprehensive copy number profiles of breast cancer cell model genomes. Breast Cancer Res. 8 (2006) R9
46. Simpson P.T., Gale T., Reis-Filho J.S., Jones C., Parry S., Steele D., Cossu A., Budroni M., Palmieri G., and Lakhani S.R. Distribution and significance of 14-3-3sigma, a novel myoepithelial marker, in normal, benign, and malignant breast tissue. J. Pathol. 202 (2004) 274-285
47. Snijders A.M., Nowak N., Segraves R., Blackwood S., Brown N., Conroy J., Hamilton G., Hindle A.K., Huey B., Kimura K., et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat. Genet. 29 (2001) 263-264
48. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98 (2001) 10869-10874
49. Souchelnytskyi S. Proteomics in studies of signal transduction in epithelial cells. J. Mammary Gland Biol. Neoplasia 7 (2002) 359-371
50. Stingl J., Eaves C.J., Kuusk U., and Emerman J.T. Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast. Differentiation 63 (1998) 201-213
51. Tibshirani R., Hastie T., Narasimhan B., and Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. USA 99 (2002) 6567-6572
52. Tirkkonen M., Tanner M., Karhu R., Kallioniemi A., Isola J., and Kallioniemi O.P. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 21 (1998) 177-184
53. Tracy S., Mukohara T., Hansen M., Meyerson M., Johnson B.E., and Janne P.A. Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255. Cancer Res. 64 (2004) 7241-7244
54. Vogel C.L., Cobleigh M.A., Tripathy D., Gutheil J.C., Harris L.N., Fehrenbacher L., Slamon D.J., Murphy M., Novotny W.F., Burchmore M., et al. First-line Herceptin monotherapy in metastatic breast cancer. Oncology 61 Suppl 2 (2001) 37-42
55. Vogel C.L., Reddy J.C., and Reyno L.M. Efficacy of trastuzumab. Cancer Res. 65 (2005) 2044
56. Wouters L., Gohlmann H.W., Bijnens L., Kass S.U., Molenberghs G., and Lewi P.J. Graphical exploration of gene expression data: a comparative study of three multivariate methods. Biometrics 59 (2003) 1131-1139
57. Zhao X., Li C., Paez J.G., Chin K., Janne P.A., Chen T.H., Girard L., Minna J., Christiani D., Leo C., et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res. 64 (2004) 3060-3071